No | Sex | Age | AIG stage | PC antibody | IF antibody | positive items | Gastrin (pg/mL) | Endoscopic corpus atrophy | PG I (ng/mL) | PG II (ng/mL) | PG I/II ratio | PG test | Vitamin B12 (pg/mL) | H. pylori infection | Comments |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 63 | Florid | 160 | Positive | 1 | 1250 | O-3 | 64.8 | 18.5 | 3.5 | − | 1060 | Past | Using B12-containing agents |
2 | F | 68 | Florid | 40 | NE | 3 | 1800 | O-p | 4.2 | 7.9 | 0.5 | 3 + | 188 | Past | |
3 | F | 53 | Florid | 80 | NE | 4 | 1400 | O-p | 11.4 | 9.4 | 1.2 | 3 + | 97 | Past | |
4 | F | 60 | Florid | 80 | NE | 4 | 2180 | O-p | 10.4 | 11.7 | 0.9 | 3 + | 157 | Past | |
5 | F | 66 | End | 40 | NE | 2 | 972 | O-p | NE | NE | NE | NE | 183 | Past | |
6 | M | 43 | End | 80 | NE | 2 | 1170 | O-1 | NE | NE | NE | NE | 86 | No | |
7 | F | 77 | End | 80 | NE | 2 | 1110 | O-p | 71.9 | 39.2 | 1.8 | − | 247 | Past | |
8 | F | 70 | End | 10 | NE | 3 | 851 | O-p | 33.3 | 25.9 | 1.3 | 2 + | 71 | Past | |
9 | F | 44 | End | 20 | NE | 3 | 5300 | O-p | 3.1 | 5.2 | 0.6 | 3 + | 270 | No | |
10 | F | 81 | End | 40 | NE | 3 | 4020 | O-p | 4.4 | 4.4 | 1 | 3 + | 236 | No | |
11 | F | 81 | End | 80 | NE | 3 | 696 | O-p | 6.9 | 13.5 | 0.5 | 3 + | 320 | Past | |
12 | M | 53 | End | 160 | NE | 3 | 720 | O-p | 7.1 | 7.3 | 1 | 3 + | 180 | Past | |
13 | F | 66 | End | 160 | NE | 3 | 2250 | O-p | 8.4 | 6.3 | 1.3 | 3 + | 435 | Past | Using B12-containing agents |
14 | M | 78 | End | 10 | NE | 4 | 708 | O-p | 2.5 | 3.7 | 0.7 | 3 + | 56 | No | |
15 | F | 60 | End | 20 | NE | 4 | 5000 | O-p | 9.1 | 10.9 | 0.8 | 3 + | 105 | No | |
16 | M | 67 | End | 20 | NE | 4 | 2170 | O-p | 2.5 | 5.3 | 0.5 | 3 + | 50 | Past | |
17 | F | 70 | End | 20 | NE | 4 | 5017 | O-p | 3.7 | 11.9 | 0.3 | 3 + | 70 | Past | |
18 | M | 71 | End | 20 | NE | 4 | 4054 | O-p | 8.8 | 4.9 | 1.8 | 3 + | 51 | No | |
19 | F | 71 | End | 20 | NE | 4 | 690 | O-p | 3.8 | 4.6 | 0.8 | 3 + | 52 | No | |
20 | F | 56 | End | 40 | NE | 4 | 2493 | O-p | 2.7 | 7.9 | 0.3 | 3 + | 92 | No | |
21 | F | 79 | End | 40 | NE | 4 | 3350 | O-p | 3.1 | 11.1 | 0.3 | 3 + | 116 | No | |
22 | M | 57 | End | 160 | NE | 4 | 1600 | O-p | 4.6 | 7.9 | 0.6 | 3 + | 122 | No | |
23 | M | 73 | Not AIG | 10 | NE | 1 | 307 | O-3 | 17.5 | 7.4 | 2.4 | 2 + | 330 | Past | |
24 | F | 68 | Not AIG | 20 | NE | 1 | 93 | O-p | 70.6 | 11.2 | 6.3 | − | 377 | Past | |
25 | F | 65 | Not AIG | 40 | NE | 1 | 121 | O-p | 22.9 | 4.7 | 4.9 | − | 479 | Past | |
26 | M | 67 | Not AIG | 80 | NE | 1 | 72 | O-3 | 23.1 | 4.9 | 4.7 | − | 178 | Past | |
27 | F | 73 | Not AIG | 10 | NE | 2 | 300 | O-p | 20.7 | 6.1 | 3.4 | − | 623 | Past | |
28 | M | 80 | Not AIG | 10 | NE | 2 | 195 | O-p | 5.3 | 2.3 | 2.3 | 2 + | 604 | Past | Using B12-containing agents |
COV = 172 | COV = 180 |